Trademark Overview
On Monday, July 14, 2025, a trademark application was filed for MSK with the United States Patent and Trademark Office. The USPTO has given the MSK trademark a serial number of 99281840. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 14, 2025. This trademark is owned by Memorial Sloan-Kettering Cancer Center. The MSK trademark is filed in the Insurance & Financial Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, training clinicians and healthcare providers in analysis of clinical data utilizing diagnostic, clinic-genomic, and harmonized oncologic dataset and database models pertaining to cancer outcome predictions and treatment recommendations; Educational services, namely, conducting community lectures on cancer and related health issues, and distribution of related informational materials therewith; Educational services, namely, conducting classes, seminars, training programs, correspondence courses, and scientific conferences via television, radio, and global computer networks, all in the fields of medicine and biomedical sciences.
Charitable fundraising services by means of raising money for cancer research, cancer treatment, cancer awareness and the construction of facilities for use in cancer research, cancer treatment and cancer awareness.
Medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; pharmaceutical prescription formulation being compounding, and dispensing services; providing medical services in the nature of patient health consultations for patients and providing medical information via telemedicine, videoconferencing, and teleconferencing software
Research in the biomedical sciences fields, including molecular biology, cell biology, genetics, and immunology; medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; Pharmaceutical prescription formulation being compounding, and dispensing services; Providing medical services in the nature of patient consultations and medical information via telemedicine; Medical initiative and research and development services pertaining to the development of cancer vaccines that target neoantigens; Scientific research services in the biomedical sciences fields, including molecular biology, cell biology, genetics, and immunology; Compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluation and assessing tumor biology, prognosis, and treatment and patient drug response; Providing non-downloadable on-line software, software applications, software tools, and databases using natural langua...
